KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Total Non-Current Liabilities (2016 - 2025)

Teladoc Health's Total Non-Current Liabilities history spans 12 years, with the latest figure at $1.5 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 27.3% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, down 27.3%, while the annual FY2025 figure was $1.5 billion, 27.3% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $1.5 billion at Teladoc Health, down from $1.5 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.1 billion in Q4 2023 and bottomed at $56.1 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $889.0 million (2023), against an average of $966.6 million.
  • The largest annual shift saw Total Non-Current Liabilities surged 3391.57% in 2021 before it plummeted 96.0% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $93.1 million in 2021, then soared by 52.71% to $142.2 million in 2022, then soared by 1352.52% to $2.1 billion in 2023, then decreased by 1.96% to $2.0 billion in 2024, then decreased by 27.3% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Total Non-Current Liabilities are $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).